Practical Radiation Oncology Program 2024

This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a business fundamentals review and a radiopharmaceuticals overview.

Target Audience

The activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, nurses, radiation dosimetrists, physicists, pathologists, residents, neurosurgeons, diagnostic radiologists, radiation therapists, practice managers, dietitians and urologists.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Discuss treatment options for patients with early stage breast cancer and those treated with neoadjuvant chemotherapy.
  • Discuss indications and treatment techniques for IMRT in breast cancer patients. 
  • Develop a framework for selecting the optimal treatment for patients with brain metastases.
  • Increase the tools for diagnosis and management of radionecrosis.
  • Best counsel patients on risk of neurotoxicity and options for mitigating and managing the toxicity. 
  • Describe the necessary components of maintaining a clinical practice.
  • Create a business plan advocating for a new technology or treatment.
  • Partner with clinic, hospital and organizational leaders to promote best practices in radiation oncology. 
  • Have evidence basis and comfort in treating osteoarthritis and plantar fasciitis with LD-RT.
  • Have evidence basis and comfort in treating other musculoskeletal/connective tissue disorders such as Dupuytren's and Lederhosen's.
  • Have understanding of potential treatments for tremors, dementia, depression.  
  • Describe three different intentions of radiotherapy: curative, disease-modifying and palliative radiotherapy.
  • List the essential components of having time-sensitive, meaningful conversations with patients and families about goals and values that can influence radiotherapy decision making. 
  • Determine the appropriate dose constraints to be utilized in common clinical situations including SBRT to central and peripheral lung lesions.
  • Assess common side effects of lung treatment and determine appropriate management. 
  • Describe the molecular pathologic features that should be included in pathology report for endometrial, vulvar and cervix cancers. 
  • Be able to discuss how pathologic factors, such as molecular status, influence prognosis and treatment decisions. 
  • Discuss recent clinical trial data for the management of gynecologic cancers and define what patient populations show survival benefits with these new approaches, such as immunotherapy. 
  • Be aware of the motivation and evidence for treating suitable prostate patients with SBRT. 
  • Feel confident in contouring, treatment planning and delivery of prostate SBRT. Be cognizant of tips to reducing side effects. 
  • Be familiar with approaches to building a successful community prostate SBRT program including advice on successful team building, marketing and reimbursement. 
  • Explain planning techniques to prevent treatment related side effects from head and neck cancer radiation. 
  • Describe management techniques to treat acute and late side effects from radiation to the head and neck. 
  • Identify indications for radiopharmaceuticals for prostate cancer.
  • Identify resources needed to implement radiopharmaceuticals in a community clinic.   
Course summary
Available credit: 
  • 12.50 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 12.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 12.50 Certificate of Attendance
    This activity was designated for 12.50 AMA PRA Category 1 Credit™.
Course opens: 
12/02/2024
Course expires: 
12/31/2025
Cost:
$699.00
Rating: 
0

The program is comprised of ten sessions: 

  1. Advances in Breast Cancer Management: Early-Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment
    • To Treat or Not To Treat: Patients with Early Stage Breast Cancer - Janice Lyons, MD
    • Radiation Therapy for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy - Lisa Singer, MD, PhD
    • Indications and Techniques for Breast IMRT - Laura Warren, MD
  2. Brain Metastases Radiotherapy while Mitigating Radionecrosis and Neurotoxicity
    • Tailored Approach to Brain Metastases Management - Stuart Burri, MD
    • Mitigating and Managing Neurotoxicity from Radiotherapy for Brain Metastases - William Breen, MD
    • Prevention and Management Strategies for Radionecrosis - Raj Singh, MD
  3. Business of Radiation Oncology for Clinicians
    • Running a Private Practice - Christopher Jahraus, MD
    • How to Be a Partner with Your Business Manager - Curtiland Deville, MD, FASTRO
    • How to Build a Business Plan - Becki Swanson, OCN, BSN, RN, MSHA
    • What Academicians Need to Know About the Business of Radiation Oncology - Kimberly Smith, MPA
  4. Benign Radiotherapy: Back to the Future
    • LDRT for Osteoarthritis and Plantar Fasciitis - Nagendra (Bobby) Koneru, MD, FASTRO
    • Pain, Pain, Go Away...LD-RT in Dupuytrens Contracture and Other Musculoskeletal Disorders - Mudit Chowdhary, MD
    • Benign CNS: Opportunities and State of the Art - Jona Hattangadi-Gluth, MD, FASTRO
  5. Patient Guided Radiotherapy: Tools to Help Providers Support Patients when the "Right Choice" Isn't Always Clear
    • Goals of Care Conversations for the Radiation Oncologist - Emily Martin, MD
    • Defining Radiotherapy Intent - Joshua Jones, MD
  6. Prevention and Management of Toxicity in Organs at Risk (OAR)
    • Lung OAR: Conventional Fractionated Treatment - Julianna Bronk, MD, PhD
    • Lung OAR: Central and Ultracentral SBRT - Matthew Ning, MD, MPH
    • Lung OAR: Peripheral Lung SBRT - Shane Mesko, MD, MBA
  7. Gynecologic Tumor Board - Case-Based Discussion of the Molecular and Treatment Approach Updates for the Management of Endometrial, Vulvar and Cervical Cancers
    • Gynecologic Molecular Pathology Review for Endometrial, Vulvar and Cervix Cancers - Taylor Jenkins, MD
    • Endometrial Cancer Staging and Treatment Updates - The Significance of Pathology and Molecular Status - Susan Gueble, MD, PhD
    • Vulvar and Cervical Cancer Treatment Updates - Junzo Chino, MD, FASTRO
  8. Implementation of a Prostate SBRT Program in the Community Setting
    • Evidence that SBRT is a New Standard of Care for Localized Prostate Cancer - Nicholas van As, MD, MB
    • Building a Successful Community Prostate SBRT Practice - Jonathan Haas, MD
    • How to Safely Deliver Prostate SBRT in a Community Setting - Michael Zelefsky, MD, FASTRO 
  9. Head and Neck Cancer - Prevention and Management of Radiation Therapy Toxicity
    • Reduction in Head and Neck Cancer Toxicity: Simulation and Planning Considerations - Shauna Campbell, MD, DO
    • Management of Acute Toxicity from Head and Neck Radiation Therapy - Carryn Anderson, MD, FASTRO
    • Treatment of Late Toxicity from Head and Neck Radiation Therapy - Darrion Mitchell, MD, PhD 
  10. Introduction to Theranostics for the Community Radiation Oncologist
    • Radiopharmaceuticals for Prostate Cancer - Jeff Michalski, MD, MBA, FASTRO
    • Delivering Radiopharmaceuticals within a Radiation Oncology Clinic - Youssef Charara, PhD
    • Implementing a Multidisciplinary Theranostics Program in a Community Setting - Brandon Mancini, MD, MBA  

This activity is available from December 2, 2024, through 11:59 p.m. Eastern time on December 31, 2025.

This activity was originally recorded at the 2024 ASTRO Annual Meeting.

Faculty:

NameEmployment RelationshipsConsulting or Advisory Board/Speaker/Faculty/Research/HonorariaOwnerships/Investments/Intellectual PropertyLeadership/Positions of Authority
Carryn AndersonHeartland Anesthesia: Chief Operating Officer: Employee
University of Iowa Hospitals & Clinics: Radiation Oncologist: Employee
Galera Therapeutics, Inc: Consultant, Research: Recipient: My Institution: Salary Support: No: site principal investigator: Drug development to mitigate oral mucositis: Compensation/Payment, Uncompensated: Member of consulting focus group for development of healthcare provider and patient education materials related to potential commercial launch of avasopasem manganese for oral mucositis in head and neck cancer patients receiving cisplatin & RT.: PresentNoneUniversity of Iowa Hospitals & Clinics: Residency Program Director: Maintain ACGME accreditation for Radiation Oncology program: Compensation? No: Relationship ended 03/30/2023
William BreenMayo Clinic: Radiation Oncologist: EmployeeGE Healthcare: Advisory Board: Single: Access to company proprietary information or provide your expertise; or any public-facing use of your name/image: No: Compensation/Payment, Other-Paid to institution: Discussion of development of novel PET/CT radiotracers, all funds paid to department.: January 2023
Miltenyi: Advisory Board: Single: Access to company proprietary information or provide your expertise; or any public-facing use of your name/image: No: Compensation/Payment, Other-Paid to institution: CAR-T development for CNS lymphoma: 5/29/24
NoneNone
Julianna BronkUniversity of Texas MD Anderson Cancer Center: Assistant Professor: EmployeeNoneNoneNone
Stuart BurriSoutheast Radiation Oncology Group: President and Partner: PartnerNovocure: Other-Data Safety monitoring committee: Travel expenses, Compensation/Payment: Member of data safety monitoring board for the METIS trial: 2023Charlotte Physics Holding: Ownership equity: Partial owner of holding company that owns an interest in a physics staffing company
FUSE Oncology Holding: Ownership equity: Own a partial stake of a holding company that owns a portion of FUSE Oncology
Oncology Practice Solutions: Ownership equity: Own a portion and am a managing partner of Oncology Practice Solutions
Radiation Oncology Centers of the Carolinas: Ownership equity: Partial owner
Southeast Radiation Oncology Group: Partnership: President and partner
Atrium Health - Levine Cancer Institute: A large non-profit health system: Chairman of Radiation Oncology: Chairman of Radiation Oncology: Compensation? No
Shauna CampbellCleveland Clinic Foundation: Radiation Oncologist: EmployeeNoneNoneNone
Youssef ChararaHoward University: Adjunct professor: Employee: May 2024
V
irginia Cancer Specialists: Chief Medical Physicist: Employee
Novartis/aaa: Consultant: Compensation/Payment, Other-TBD: consultant on RLT experience: PresentNoneNone
Junzo ChinoDuke University Health System: Associate Professor: EmployeeGOG Foundation: Other-Received Stipend for writing (GOG foundation book): Honoraria: Honoraria for writing: 4/10/23
Guidepoint: Consultant: Compensation/Payment: Investment Consulting - Platinum Therapy: 10/9/23
KM Pharmaceutical Consulting LLC: Other-Data and Safety Monitoring Board for ongoing trial: Honoraria: Data and Safety Monitoring Board for ongoing trial for Cervical Cancer: To present
Merck: Advisory Board: Single: Access to company proprietary information or provide your expertise; or any public-facing use of your name/image: No: Grant/research funding: Pembrolizumab in Cervical Cancer: 1/22/24
Stryker: Consultant: Honoraria: Airo CT Consulting: 4/30/23
NoneAmerican Brachytherapy Society: Medical Society: Board Member: Board Member: Compensation? No
Mudit ChowdharyNorthside Hospital: Radiation Oncologist: EmployeeNoneNoneNone
Christine ChungAlta Bates Comprehensive Cancer Center; H. Lee Moffitt Cancer CenterNoneNoneNone
Sean CollinsDepartment of Radiation Medicine, MedStar Georgetown University HospitalAccuray: Consultant: Honoraria: clinical consultation: PresentNoneNone
Curtiland DevilleJohns Hopkins University: Associate Professor: Employee
None
NoneASTRO: Vice Chair, Council on Health Equity, Diversity & Inclusion: Board of Directors: Compensation? No
ASTRO Red Journal: Deputy Editor: Deputy Editor: Compensation? No
Virginia DiavolitsisOhio State University: Physician: Partner
Riverside Radiation Oncology: Physician: Partner
NoneNoneNone
Beant GillAssociates in Radiation Medicine: Physician: Partner
Luminis Health: Physician: Employee
The George Washington University: Other-Faculty: Uncompensated: Clinical role for mentorship and teaching students: PresentAssociates in Radiation Medicine: Ownership equity: Partner: Partnership: Partner: Ownership equity: Partner: Partnership: PartnerAmerican College of Radiology: Organization for radiology and radiation oncology: CAC Representative: Representative for local coverage determination review of radiation oncology services: Compensation? No
Chesapeake Potomac Regional Cancer Center: Community practice for radiation oncology services: Medical Director: Medical director for clinical operations: Compensation? No
Susan GuebleYale School of Medicine: Assistant Professor: Employee
Yale-New Haven Hospital: Radiation Oncology Resident: Employee: Relationship ended 06/30/2023
National Institutes of Health: Research: Recipient: Me: Salary Support: Yes: national/overall principal investigator: Basic/translational oncology research: Grant/research funding, Salary support: Principal Investigator on NIH Grant 1DP5OD036128 "Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer": 7/31/2028
Spector Family Fund for Clinical Research and Investigation: Research: Recipient: Me: Salary Support: No: Principal Investigator on Internal Award: Basic/translational oncology research: Grant/research funding: Principal Investigator on Spector Family Fund for Clinical Research and Investigation and Yale Physician Scientist Development Internal Award "Overcoming Temozolomide Resistance with a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in Non-Glioma Cancers": 6/30/2025
Yale SPORE in Skin Cancer: Research: Recipient: Me: Salary Support: No: Principal Investigator on Internal Award: Basic/translational oncology research: Grant/research funding: Principal Investigator on Career Enhancement Program Internal Award from Yale SPORE in Skin Cancer "Defining the Interactions of a Novel DNA Modifying Agent with Melanoma-Specific Genetic Features and Molecular Targeted Agents": 8/31/2024
Modifi Biosciences: Copyright/Patent/License/Royalty: Receive royalty distribution of licensing for "Mechanism of action of KL-50 a lead compound for the treatment of drug-resistant glioblastoma"Yale Cancer Center: Neuroendocrine Tumor Program Steering Committee: Member: Member of the Yale Cancer Center Neuroendocrine Tumor Program Steering Committee: Compensation? No
Jonathan HaasNYU Langone Hospital-Long Island: Chairman: EmployeeAccuray: Education/Meeting Faculty, Speaker's Bureau: Honoraria: speaker: PresentNoneNone
Jona Hattangadi-GluthUC San Diego/Moores Cancer Center: Professor: EmployeeNoneNoneNone
Christopher JahrausGenerations Radiotherapy & Oncology PC: Owner & Physician: PartnerElekta: Consultant, Advisory Board, Speaker's Bureau: Ongoing: Access to company proprietary information or provide your expertise; or any public-facing use of your name/image: Yes: Honoraria, Travel expenses, Compensation/Payment: I have spoken about their product SmartClinic in numerous venues and served on multiple customer advisory committees.: To Present
RADformation: Consultant: Other-Provision of software.: I have worked with RADformation to assist them in developing their products in the Elekta OIS environment.: To Present
Drug Patent: Ownership equity: I am co-maker of a patent for use of rifaximin in radiotherapy patients. Patents have been granted in Canada, the European Union (including Spain specifically), Israel, Japan, Korea, and Russia. I have received no money whatsoever for this intellectual property nor for my rights to it.: Relationship ended 05/08/2024
Generations Radiotherapy & Oncology PC: Ownership equity: I am 100% owner of my practice.: Relationship ended 05/08/2024
American College of Radiation Oncology: I am a very active member of ACRO (and ASTRO). Within ACRO, I serve multiple roles, including those shown below.: Vice Chair, Gov't Relations & Economics Committee; Vice Chair, PAC; Deputy Editor of Journal Channel (CURiE); Chair, ACROPath; RUC-Advisor: I am a member of this organization and actively participate on a voluntary basis, frequently cooperating with ASTRO leadership in my roles at ACRO.: Compensation? No: Relationship ended 05/08/2024
Taylor JenkinsVCU: Assistant Professor: EmployeeNoneNoneNone
Joshua JonesChildren's Hospital of Philadelphia: Pediatrician: Employee: Relationship ended 06/30/2023
Pediatric Urgent Car of Rochester: Pediatrician: Employee
Rochester Regional Health: Radiation Oncologist: Employee
University of Pennsylvania Health System: Associate Professor of Radiation Oncology: Employee: Relationship ended 05/12/2023
NoneNoneNone
Elizabeth KiddStanford University: Associate Professor: EmployeeViewray: Research: Recipient: My Institution: Salary Support: No: site principal investigator: Use of viewray for fractionated radiation: Grant/research funding: Use of viewray for cervix cancer fractionated radiation: Aug. 2023NoneABS Quality & Safety Standard Committee: Co-Leader: Oversee the ABS Quality and Safety Standards Committee.: Compensation? No
Nagendra (Bobby) KoneruLeonard C. Ferguson Cancer Center: Radiation Oncologist: EmployeeIORBC: Advisory Board: Ongoing: Access to company proprietary information or provide your expertise; or any public-facing use of your name/image: Yes: Uncompensated: Board Member: PresentNoneNone
Janice LyonsUniversity Hospitals Seidman Cancer Center: Radiation Oncologist: EmployeePrimum: Other-I serve as a breast cancer expert answering questions posed by the community physicians: Honoraria: I receive compensation for each question answered.: PresentNoneABR: ABR exam development: Member: Help develop the ABR oral exam and administer the ABR oral exam: Compensation? No
ASTRO: ASTRO PBI guideline: Chair: Chairing the PBI guideline committee: Compensation? No
NCCN: NCCN breast cancer guideline committee: Member: Help update the breast cancer guidelines, review the radiation compendium: Compensation? No
Brandon ManciniBAMF Health: Medical Director: Employee
West Michigan Cancer Center: Radiation Oncologist: Employee: Relationship ended 03/13/2022
GE HealthCare: Advisory Board, Speaker's Bureau: Ongoing: Access to company proprietary information or provide your expertise; or any public-facing use of your name/image: Yes: Honoraria, Travel expenses: Speaker's Bureau with industry presentation at the 2023 SNMMI Annual Meeting on the advancement of radiopharmaceutical treatment/care. Asked to serve on a Theranostics Advisory Board.: To Present
GoodRx Health: Consultant: Compensation/Payment: Ad hoc editing/revision of prostate cancer-related educational articles: To Present
MCG Health: Consultant: Compensation/Payment: Consultant to evaluate and edit/revise medical guidelines.: To Present
BAMF Health, Inc.: Ownership equity: Medical DirectorBAMF Health: Medical Director: Serve as Medical Director in addition to primary role as a physician providing patient care.: Compensation? No
Emily MartinUniversity of California, Los Angeles: Assistant Clinical Professor: EmployeeNoneNoneNone
Shane MeskoScripps Cancer Center: Radiation Oncologist: EmployeeOscar Health: Consultant: Compensation/Payment: Independent Consultant for coverage guidelines: To PresentNoneNone
Jeff MichalskiWashington University School of Medicine: Professor: EmployeeMichalski and Associates: Consultant: Travel expenses, Compensation/Payment: Consultatn: To present
NCI: Research: Recipient: My Institution: Salary Support: No: co-investigator: Radium-223; Improving Response and Toxicities: Grant/research funding: Coinvestigator: To present
NoneNCI: GU Steering Committee: Co-Chair: Oversee portfolio of NCI NCTN clinical trials in genitourinary cancers.: Compensation? No
RTOG Foundation: nonprofit organization dedicated to improving outcomes for cancer patients through the conduct of practice changing clinical trials.: Treasurer: Treasurer and board of directors: Compensation? No
Darrion MitchellThe Ohio State University: Assistant Professor: EmployeeNoneNoneNone
Matthew NingUT MD Anderson Cancer Center: Assistant Professor: EmployeeNoneNoneNone
Simul ParikhLake Huron Medical Center: Radiation Oncologist: EmployeeNoneNoneNone
Christopher Hays PopeCARTINoneNoneNone
Malolan RajagopalanMount Carmel Health System; Radiology, Inc.NoneNoneNone
Avani RaoRadiation Oncology Associates of the National Capital Region: Associate: EmployeeNoneNoneNone
Arshin SheybaniUnityPoint Health: Physician: EmployeeNoneNoneASTRO: Nominating Committee: community practice physician: member of ASTRO nominating committee for leadership appointments: Compensation? No
ASTROnews: magazine publication for ASTRO: editorial board member: select topics for publication: Compensation? No
IWORC-NCORP: review NCORP grant: board member: voting member to designate inclusion of cancer centers and providers into our NCORP: Compensation? No
Rectal Anal Task Force: a subcommittee of the NCI GI steering committee: community oncologist representative: a member of the committee with 3 year term. we have monthly meetings to discuss development of clinical trials for rectal and anal cancers: Compensation? No
Lisa SingerUniversity of California, San Francisco: Assistant Professor: EmployeeUCSF PIPE: Research: Recipient: Me: Salary Support: Yes: site principal investigator: Simulation-Based Education: Grant/research funding: Simulation-Based Education: 6/30/2023NoneAmerican Board of MR Safety: Board of Directors: Board of Directors: Board of Directors: Compensation? No
Raj SinghThe Ohio State University Wexner Medical Center: Assistant Professor/Physician: Employee
Virginia Commonwealth University Health System: Resident Physician: Employee: Relationship ended 06/30/2023
NoneNoneNone
Kimberly SmithDepartment of Radiation Oncology, Icahn School of Medicine at Mount SinaiElekta: Advisory Board: Ongoing: Access to company proprietary information or provide your expertise; or any public-facing use of your name/image: No: Travel expenses, Compensation/Payment: Serve as member on advisory board providing operational feedback to assist company in the production of software to assist in workflow efficiencies.: PresentNoneNone
Becki SwansonAdventHealth: Executive Director Cancer Institute: EmployeeNoneNoneNone
Nicholas van AsThe Royal Marsden NHS Foundation TrustAccuray: Education/Meeting Faculty, Speaker's Bureau: Grant/research funding: Chief investigator: 2025NoneNone
Laura WarrenBrigham and Women's Physician Organization: Physician: EmployeeNoneNoneNone
Michael ZelefskyMemorial Sloan Kettering Cancer Center: Attending Physician: Employee: Relationship ended 04/01/2024
NYU Langone Medical Center: Attending Physician: Employee
Boston Scientific: Consultant: Compensation/Payment: Consultant: PresentNoneBrachytherapy Journal: Journal: Editor in Chief: Editor/Manuscripts: Compensation? Yes

Planners:

The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Commitee had control over the content of this activity.

All relevant financial relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

Available Credit

  • 12.50 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 12.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 12.50 Certificate of Attendance
    This activity was designated for 12.50 AMA PRA Category 1 Credit™.
 
Status
Price
Title
$699.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$699.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

Nonmember: $699
Member: $599
Postdoctoral Fellow Member: $299
Member-in-Training: $299
Student/Grad Student/PGY-1 Member: $299

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those registrants. Including those who for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement

The course and its materials will only be available on the ASTRO website until December 31, 2025 regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.